NOTE 10 - | NET LOSS PER SHARE ATTRIBUTABLE TO ORDINARY SHAREHOLDERS |
The following table
sets forth the computation of basic and diluted net loss per share attributable to ordinary shareholders for the periods presented:
| |
For the Three Months Ended | | |
For the Six Months Ended | |
| |
June 30, 2025 | | |
| | |
June 30, 2025 | | |
| |
Numerator: | |
| | |
| | |
| | |
| |
Net loss for the period | |
$ | (10,736 | ) | |
$ | (23,087 | ) | |
$ | (21,514 | ) | |
$ | (36,334 | ) |
Deemed dividend on issuance of warrants | |
| - | | |
| - | | |
| (81 | ) | |
| - | |
| |
| | | |
| | | |
| | | |
| | |
Net loss attributable to ordinary shareholders, basic and diluted | |
$ | (10,736 | ) | |
$ | (23,087 | ) | |
$ | (21,595 | ) | |
$ | (36,334 | ) |
Denominator: | |
| | | |
| | | |
| | | |
| | |
Weighted-average shares used in computing net loss per share attributable to ordinary shareholders, basic and diluted | |
| 18,738,657 | | |
| 8,869,691 | | |
| 18,732,196 | | |
| 7,072,950 | |
Net loss per share attributable to ordinary shareholders, basic and diluted | |
$ | (0.57 | ) | |
$ | (2.60 | ) | |
$ | (1.15 | ) | |
$ | (5.14 | ) |
The following instruments were not included
in the computation of diluted earnings per share because of their anti-dilutive effect:
For the period ending
on June 30, 2025:
| - | Warrants to purchase ordinary shares; |
| - | Share-based compensation; |
For the period ending
on June 30, 2024:
| - | Redeemable convertible preferred shares; |
| - | Convertible loan agreements; |
| - | Warrants to purchase ordinary shares; |
| - | Share-based compensation. |
|